A Study of the Treatment of Postmenopausal Women With Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

August 31, 2004

Conditions
Osteoporosis, Post-Menopausal
Interventions
DRUG

teriparatide 20 micrograms/day subcutaneous

DRUG

salmon calcitonin 100 IU/day subcutaneous

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hong Kong

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Shatin

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00543023 - A Study of the Treatment of Postmenopausal Women With Osteoporosis | Biotech Hunter | Biotech Hunter